BBBenedict Barnes

Benedict Barnes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Benedict Barnes has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Anders Dalsgaard

    Food Safety and Zoonoses, Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Stigböjlen 4, 1870 Frederiksberg C, Denmark

    1 shared publication
  • Anders Permin

    Office for Innovation and Sector Services, Administration, Technical University of Denmark, Anker Engelunds Vej, 2800 Kgs Lyngby, Denmark

    1 shared publication
  • Emmanuel De-Graft Johnson Owusu-Ansah

    Department of Mathematics, College of Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

    1 shared publication
  • Robert Abaidoo

    Department of Theoretical and Applied Biology, Faculty of Bio Science, College of Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

    1 shared publication
  • Tine Hald

    National Food Institute, Technical University of Denmark, 2800 Kongens Lyngby, Denmark

    1 shared publication
  • Torben Wilde Schou

    Environment and Toxicology, DHI, Horsholm, Denmark

    1 shared publication

Latest Publications

  • Open Access

    Probabilistic modeling for an integrated temporary acquired immunity with norovirus epidemiological data

    by Emmanuel De-Graft Johnson Owusu-Ansah, Benedict Barnes, Robert Abaidoo, Hald Tine, Anders Dalsgaard, Anders Permin, Torben Wilde Schou

    Integration of acquired immunity into microbial risk assessment for illness incidence is of no doubt essential for the study of susceptibility to illness. In this study, a probabilistic model was set up as dose response for infection and a mathematical derivation was carried out by integrating immunity to obtain probability of illness models. Temporary acquire immunity from epidemiology studies which includes six different Norovirus transmission scenarios such as symptomatic individuals infectious, pre- and post-symptomatic infectiousness (low and high), innate genetic resistance, genogroup 2 type 4 and those with no immune boosting by asymptomatic infection were evaluated. Simulated results on illness inflation factor as a function of dose and exposure indicated that high frequency exposures had immense immunity build up even at high dose levels; hence minimized the probability of illness. Using Norovirus transmission dynamics data, results showed, and immunity included models had a reduction of 2-6 logs of magnitude difference in disease burden for both population and individual probable illness incidence. Additionally, the magnitude order of illness for each dose response remained largely the same for all transmission scenarios; symptomatic infectiousness and no immune boosting after asymptomatic infectiousness also remained the same throughout. With integration of epidemiological data on acquired immunity into the risk assessment, more realistic results were achieved signifying an overestimation of probable risk of illness when epidemiological immunity data are not included. This finding supported the call for rigorous integration of temporary acquired immunity in dose-response in all microbial risk assessments.